{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:45:50Z","timestamp":1785937550176,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.atherosclerosis.2021.09.015","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T10:43:35Z","timestamp":1631702615000},"page":"41-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Hemoglobin concentration, hematocrit and red blood cell count predict major adverse cardiovascular events in patients with familial hypercholesterolemia"],"prefix":"10.1016","volume":"335","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7555-1275","authenticated-orcid":false,"given":"Martine","family":"Paquette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Baass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gim.2017.151","article-title":"Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis","volume":"20","author":"Chora","year":"2018","journal-title":"Genet. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib2","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib3","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib4","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2018.08.010","article-title":"High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: the French Familial Hypercholesterolemia Registry","volume":"277","author":"B\u00e9liard","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MOL.0000000000000519","article-title":"Predicting cardiovascular disease in familial hypercholesterolemia","volume":"29","author":"Paquette","year":"2018","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2016.10.004","article-title":"The Montreal-FH-SCORE: a new score to predict cardiovascular events in familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib8","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1038\/s41598-018-21661-x","article-title":"Elements of the complete blood count associated with cardiovascular disease incidence: findings from the EPIC-NL cohort study","volume":"8","author":"Lassale","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/biof.1518","article-title":"The diagnostic and prognostic value of red cell distribution width in cardiovascular disease; current status and prospective","volume":"45","author":"Parizadeh","year":"2019","journal-title":"Biofactors"},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2143\/AC.57.3.2005387","article-title":"Red blood cell count in short-term prediction of cardiovascular disease incidence in the Gubbio population study","volume":"57","author":"Puddu","year":"2002","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1053\/euhj.1999.1699","article-title":"Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease","volume":"21","author":"Danesh","year":"2000","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1365-2141.1997.8532481.x","article-title":"Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study","volume":"96","author":"Lowe","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijcard.2009.10.031","article-title":"The role of red blood cells in the progression and instability of atherosclerotic plaque","volume":"142","author":"Tziakas","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0006-3495(83)84288-X","article-title":"Influence of cholesterol content on red cell membrane viscoelasticity and fluidity","volume":"44","author":"Chabanel","year":"1983","journal-title":"Biophys. J."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0026-0495(97)90255-9","article-title":"Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients","volume":"46","author":"Kohno","year":"1997","journal-title":"Metabolism"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2021.09.015_bib16","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.33549\/physiolres.933402","article-title":"The role of red blood cell deformability and Na,K-ATPase function in selected risk factors of cardiovascular diseases in humans: focus on hypertension, diabetes mellitus and hypercholesterolemia","volume":"65","author":"Radosinska","year":"2016","journal-title":"Physiol. Res."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4093\/dmj.2018.42.2.155","article-title":"Hemorheologic alterations in patients with type 2 diabetes mellitus presented with an acute myocardial infarction","volume":"42","author":"Park","year":"2018","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib18","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.jacc.2006.08.069","article-title":"Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?","volume":"49","author":"Tziakas","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib19","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.3390\/ijms22115843","article-title":"Erythrocytes: central actors in multiple scenes of atherosclerosis","volume":"22","author":"Turpin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9149(00)01429-6","article-title":"Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia","volume":"87","author":"Hopkins","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacl.2019.04.006","article-title":"LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia","volume":"13","author":"Paquette","year":"2019","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib22","article-title":"Familial hypercholesterolemia-risk-score: a new score predicting cardiovascular events and cardiovascular mortality in familial hypercholesterolemia","author":"Paquette","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib23","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/jocs.14192","article-title":"Can red blood cell distribution width predict long-term cardiovascular event after off-pump coronary artery bypass? A retrospective study","volume":"34","author":"Wu","year":"2019","journal-title":"J. Card. Surg."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40520-017-0791-y","article-title":"Hematological parameters and all-cause mortality: a prospective study of older people","volume":"30","author":"Fr\u0105ckiewicz","year":"2018","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib25","article-title":"Association between changes in hemoglobin concentration and cardiovascular risks and all-cause mortality among young women","volume":"7","author":"Lee","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10654-014-9929-9","article-title":"Anemia in the general population: prevalence, clinical correlates and prognostic impact","volume":"29","author":"Martinsson","year":"2014","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib27","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/01.CIR.0000162477.70955.5F","article-title":"Association of hemoglobin levels with clinical outcomes in acute coronary syndromes","volume":"111","author":"Sabatine","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib28","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-8703(94)90679-3","article-title":"Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up","volume":"127","author":"Gagnon","year":"1994","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1067\/mhj.2001.118467","article-title":"Hematocrit and the risk of coronary heart disease mortality","volume":"142","author":"Brown","year":"2001","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ypmed.2016.09.003","article-title":"The effect of hematocrit and hemoglobin on the risk of ischemic heart disease: a Mendelian randomization study","volume":"91","author":"Zhong","year":"2016","journal-title":"Prev. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib31","first-page":"915","article-title":"Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"Steinberg","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ebiom.2019.08.014","article-title":"New insights into the role of iron in inflammation and atherosclerosis","volume":"47","author":"Cornelissen","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1185\/030079903125002289","article-title":"The mechanistic relationships between hemorheological characteristics and cardiovascular disease","volume":"19","author":"Kensey","year":"2003","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0267659113505637","article-title":"Cardiovascular benefits of phlebotomy: relationship to changes in hemorheological variables","volume":"29","author":"Holsworth","year":"2014","journal-title":"Perfusion"},{"key":"10.1016\/j.atherosclerosis.2021.09.015_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22124","article-title":"Association of hematocrit with blood pressure and hypertension","volume":"31","author":"Emamian","year":"2017","journal-title":"J. Clin. Lab. Anal."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021013447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021013447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:48:18Z","timestamp":1758156498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021013447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":35,"alternative-id":["S0021915021013447"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.09.015","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemoglobin concentration, hematocrit and red blood cell count predict major adverse cardiovascular events in patients with familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}